KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $1.5 billion.

  • Quest Diagnostics' Accounts Payables rose 1096.73% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 1096.73%. This contributed to the annual value of $1.4 billion for FY2024, which is 257.54% up from last year.
  • Latest data reveals that Quest Diagnostics reported Accounts Payables of $1.5 billion as of Q3 2025, which was up 1096.73% from $1.3 billion recorded in Q2 2025.
  • Quest Diagnostics' 5-year Accounts Payables high stood at $1.6 billion for Q3 2021, and its period low was $1.2 billion during Q3 2023.
  • In the last 5 years, Quest Diagnostics' Accounts Payables had a median value of $1.4 billion in 2024 and averaged $1.4 billion.
  • Its Accounts Payables has fluctuated over the past 5 years, first surged by 5891.95% in 2021, then plummeted by 2240.93% in 2023.
  • Quest Diagnostics' Accounts Payables (Quarter) stood at $1.6 billion in 2021, then dropped by 12.75% to $1.4 billion in 2022, then dropped by 2.65% to $1.4 billion in 2023, then rose by 2.58% to $1.4 billion in 2024, then increased by 4.52% to $1.5 billion in 2025.
  • Its Accounts Payables was $1.5 billion in Q3 2025, compared to $1.3 billion in Q2 2025 and $1.3 billion in Q1 2025.